Special Situations Digest #17

Physiomics (PYC.L) has completed a wholesale board replacement following a shareholder vote where over 75% of investors removed former chair Dr. Jim Millen. Activist Mike Whitlow was appointed executive director, while CEO Dr. Peter Sargent was retained to provide management continuity. Following the board overhaul, the company announced multiple contract wins totaling over £345,000 from international and UK-based biotech and oncology organizations. These follow-on contracts signal the new board's operational focus and confirm the leadership change is translating into commercial momentum. This commercial traction so soon after the coup de-risks the activist thesis that board change would unlock value and serves as a material revenue signal for the AIM-listed micro-cap firm.

Kaos Capital disclosed a 4.9% stake in BioRestorative Therapies (BRTX) acquired through open market purchases on May 27, 2026. The activist is demanding an immediate board meeting to discuss strategic alternatives, including a pivot from regenerative therapies into artificial intelligence opportunities. Shares of the micro-cap biotechnology company surged 53.5% in premarket trading following the disclosure. While current holdings remain below the Schedule 13D filing threshold, the demand for a meeting signals escalation risk with any future 13D filing serving as a follow-on catalyst.

Skin Elements Limited (SKN.AX) filed an application with the Australian Takeovers Panel alleging that 62 Capital Pty Ltd and a group of placement investors constitute an undisclosed associate group controlling 43.14% of the company's shares. The filing claims that voting and disposal restriction agreements exist between 62 Capital and each placement investor. These proceedings precede two extraordinary general meetings (EGMs) scheduled for June 2 and June 23, 2026, regarding director removal resolutions under sections 203D and 249D. Skin Elements seeks interim orders to adjourn the June 2 meeting and final orders capping the group's collective voting rights at 20%. If the Panel finds association, the group's voting power would be capped at 20%, neutralizing the requisitionists' ability to remove the board at the upcoming EGM and potentially unwinding the underlying Voting & Disposal Restriction Agreements.

Blue Industrial Development Co., Ltd. (006740.KS) disclosed a large shareholding report from PMA Association and related parties reporting a 33.63% stake following a 12:1 capital reduction on May 8, 2026. The group’s voting rights are restricted to 23.38% due to pledged shares, though economic ownership includes 733,627 shares held via convertible bonds. The filing specifies a purpose of influencing management, listing board composition changes, capital structure decisions, and M&A as intended actions. Special related party has 403,710 shares pledged as collateral for a KRW 1.5B loan from Orient-Western maturing June 11, 2026. This Korean large shareholding report with management-control purpose is the local equivalent of a US 13D, and the 23.38% voting power versus 33.63% economic ownership gap creates a concentrated control vector while the June 11 loan maturity adds near-term forced-sale risk.

Bulldog Investors issued a public letter urging Investcorp to buy out public shareholders of Investcorp Credit Management BDC (ICMB) for $5.04 per share. Bulldog, which holds 596,780 shares, noted that NAV fell from $10.51 in 2019 to a current share price of ~$1.40 while management fees totaled ~$43.5 million, more than double the company's $20 million market capitalization. The activist also cited a November 2025 related-party loan at an interest rate exceeding 9% that added $2.8 million in annual interest expense. These demands follow ICMB’s March 31, 2026, formation of a Special Committee and the engagement of Houlihan Lokey to review strategic alternatives. This push for a buyout at $5.04—the last pre-dilution NAV—sets a benchmark floor for the strategic review and frames the downside for Investcorp if it refuses to close the gap from the ~$1.40 share price.

Daon International disclosed a 14.9% stake in Seoul Electronics & Telecom (027040.KQ), becoming the largest shareholder following the off-market acquisition of 2,073,196 shares on May 21, 2026. The position was established at an average price of KRW 1,864 per share using KRW 3.87B in borrowings from Kratos Inc. and Song Jin-young. Under the 'management control' purpose filing, Daon International expressed intent to influence director appointments, bylaw changes, capital structure, and M&A strategy. This large shareholding report is the Korean equivalent of a 13D, although the entire 14.9% stake is pledged as collateral for acquisition loans, creating a structural overhang if the share price weakens relative to the 160% collateral maintenance ratio.

Governance Partners and JAIC filed a large shareholding report disclosing a combined 15.44% stake in Izutsuya Co., Ltd. (8260.T), an increase from their previous 12.47% aggregate position. On May 20, JAIC acquired 340,000 shares off-market at ¥727, following a May 15 business alliance agreement between JAIC and the target. The filers cited a purpose of dialogue regarding corporate governance, board composition, and capital policy, stating they may make material proposals to enhance shareholder value. Governance Partners holds 300,000 of its shares via margin trading with Matsui Securities. This disclosure represents the Japanese equivalent of a US 13D activist filing, granting the 15.44% bloc standing to requisition shareholder proposals and demand board engagement while introducing a structural overhang via the margin-trade component.

Shen Capital Partners (SCP) filed two shareholder proposals and an open letter to Pivotree (PVT) disclosing a 9.1% stake and nominating SCP founder Francis Shen to the board. SCP is demanding a non-binding advisory resolution for the company to retain an independent investment bank by September 30, 2026, to conduct a formal strategic review including a comprehensive sale process. The activist, advised by Goodmans LLP, argues that AI disruption and compressed sector multiples favor an immediate sale over the company’s ongoing transformation of its legacy IT services business. These proposals target the June 23, 2026 annual general meeting. This 9.1% holder’s specific, time-bound resolution and board seat nomination create a pre-vote catalyst at a sub-scale IT services name, framing an M&A upside arbitrage argument based on a C$1.65 reference price versus peer and precedent multiples.

Green ESG Growth No.1 PEF disclosed a 34.02% stake in Optrontec Inc. (082210.KQ), an increase from its previous 12.22% holding. On May 27, the fund acquired KRW 25B of convertible bonds and sold common shares, causing its common stock voting rights to fall from 4.88% to 4.21%. The report was filed with a management-influence purpose under Korean Capital Markets Act Article 147. Ultimate control of the fund traces to Woori Financial Group, which owns 100% of the GP, Woori Private Equity Asset Management. This filing is the Korean equivalent of a US 13D activist filing, clearing the filer to push for board changes and corporate restructuring while the acquisition of deeply in-the-money convertible bonds concentrates economic exposure ahead of a potential control squeeze.

STIC Litmus LLC reported an 18.38% stake in LabGenomics (084650.KQ) following the KRW 20 billion acquisition of convertible bonds on May 20, 2026. The 13,642,564-share position was established at a conversion price of KRW 1,466 per share using self-funded capital. STIC Litmus is an investment vehicle managed by STIC Investments Inc., a Korean private equity firm with over KRW 305B in total assets. The May 28 DART disclosure cites a management control influence purpose under Article 147 of the Capital Markets Act. This large shareholding report is the local equivalent of a US 13D, clearing the filer to push for board changes or capital restructuring as the entry via convertible bonds at a deep discount signals a structured activist play.

Nam Yun-hui and an alliance of 124 minority shareholders filed a large shareholding report disclosing a combined 5.95% stake in ENZYCHEM Lifesciences (183490.KQ). The group utilized the 'general' format under Article 147 of the Capital Markets Act with the explicit purpose of influencing management control. Stated intentions include exercising shareholder rights concerning director appointments and removals, auditor actions, bylaw changes, capital restructuring, and M&A proposals. The reporting obligation for the 5,035,780-share position arose on May 26, 2026, representing a new bloc formation with no disclosed interests in derivatives or convertible instruments. This control-purpose declaration is the Korean equivalent of a coordinated US 13D filing and clears the 124-person grassroots alliance to seek board seats or agitate for a sale without triggering a mandatory tender offer.

(7235.T) received a shareholder proposal from Flue LLC on February 12, to which the board issued a formal resolution of opposition today. Flue LLC holds 316,000 shares and is seeking the election of representative Yuki Furue as an outside director. The activist demands the immediate cessation of Super GT sponsorship and the return of allocated funds as dividends, citing a price-to-book ratio below 1x and capital inefficiency. The board defended the sponsorship as a long-term brand investment and argued that current governance is sufficient. This escalation locks in a contested AGM on June 25 as a single-issue campaigner targets a below-1x-PBR company with a demand to kill Super GT spending and redirect it all to dividends in a textbook Japanese governance arbitrage setup.

Ascender Capital Limited filed a large shareholding report on NCD Co., Ltd. (4783.T), a Tokyo-listed IT solutions provider. The Hong Kong-based investment advisory firm disclosed a 5.38% stake consisting of 446,300 shares, a reduction from its previous holding of 7.02% following market sales between May 7 and May 18, 2026. Ascender indicates the purpose of the holding is to make material proposals. This filing is the Japanese equivalent of a US 13D, and the stated intent to make material proposals signals an activist campaign to push for corporate changes at this small-cap IT services firm.

Hong Kong-domiciled investment management firm Old Peak Group Ltd. and co-filer Old Peak Limited disclosed a combined 16.00% stake in Hanshin Diesel Works (6018.T) as of May 22, 2026. The position, increased from 14.98% through on-market purchases totaling ¥2.19 billion, crossed the 15% threshold with a stated purpose of "making important proposals for the improvement and preservation of shareholder value." This Japanese equivalent of a US 13D activist filing signals intent to press for board-level changes, with the 16% stake providing meaningful blocking power and a platform for shareholder proposals at the next AGM.

An investment group led by MI2 Corp. and Takahiro Murakami filed an amended large shareholding report disclosing an 8.11% stake in AD Works Group Co., Ltd. (2982.T), an increase from 7.08%. The group added 518,100 shares between May 14 and May 18, 2026, including a 573,500-share purchase by Murakami on May 15. Stated purposes for the holding include making proposals on capital policy changes, specifically dividend increases and share buybacks. The group may acquire more than 5% in additional shares within three months if the stock is deemed undervalued. This Japanese equivalent to a US 13D puts the small-cap real estate stock in play via an explicit demand agenda for higher dividends and buybacks while creating a potential accumulation overhang.

UGS Asset Management Co., Ltd. filed a large shareholding report disclosing a 6.13% stake in Takihyo Co., Ltd. (9982.T), an increase from the previously reported 5.03% position. The filing specifies an intent to make significant proposals regarding capital efficiency, shareholder returns, and achieving a price-to-book ratio of 1x. UGS Asset Management plans to initiate immediate constructive dialogue with management and reserves the right to submit shareholder proposals depending on the progress of that engagement. The filer also indicated intentions to acquire an additional 5% stake within three months if the share price remains at levels it considers undervalued. This filing serves as the Japanese equivalent of a US 13D, and the explicit PBR 1x target suggests the activist will push for buybacks, higher dividends, or asset sales to re-rate a deeply undervalued stock.

ASIL and Wafic Rida Said announced a formal proxy solicitation for the upcoming Annual Meeting of Braemar Hotels (BHR), a real estate investment trust focused on luxury hotels and resorts. The participants filed Amendment No. 7 to their Schedule 13D and a DFAN14A on May 22, 2026, detailing their intent to file a definitive proxy statement on Schedule 14A. ASIL and Said will utilize a WHITE Universal Proxy Card to solicit votes regarding board composition and other matters. Shareholders are directed to the forthcoming definitive proxy materials for details on the proposed director slate. This filing signals a formal, non-settlement proxy contest for board seats at the upcoming Annual Meeting, setting up a direct shareholder vote on control.

Zimmer Partners, the third-largest holder in James River Group Holdings (JRVR) with a 10% stake, converted its passive 13G position to an activist 13D filing on Monday. Zimmer demands the elimination of the common dividend, the suspension of the preferred dividend, debt repayment using excess cash, and the exploration of a private placement of equity. The activist is pushing for a strategic transaction after a 2023 review ended without a deal in 2024, despite interest from Everest, Arch Capital, and Global Indemnity. James River currently trades at approximately 0.5x tangible book value per Wedbush analyst Michael Piccolo. The 13G-to-13D conversion by a top-three holder with 10% puts a concrete activist agenda on the table, making a forced sale or capital restructuring the central arbitrage.

A five-party concert group led by DOE5 Percent Co., Ltd. disclosed a combined 7.10% stake in Gunei Chemical Industry (4229.T), an increase from 6.16% representing 638,500 shares. The group updated its filing purpose to include constructive engagement and the potential for significant proposals to improve medium-to-long-term corporate value. Naturali Co., Ltd. holds 3.27% of the total stake, while individual member Mikuro Ueshima remains a 2.64% holder despite serving as a net seller in May. Substantial margin financing exists across the group, including ¥1,097.2M for Naturali and ¥241.9M for DOE5, creating a potential forced-selling overhang. This Japanese large shareholding report amendment functions as the equivalent of a US 13D with activist intent, clearing the group to pursue board-level changes while making Matsui Securities collateral calls a critical risk signal.

Hibiki Path Advisors SPC and Hibiki Path Advisors 2 SPC disclosed a combined 17.36% stake in Japan Pure Chemical Co., Ltd. (4973.T), according to an EDINET large shareholding report. The holding decreased from a prior 18.40% interest after Hibiki Path Advisors 2 SPC reduced its position from 5.73% to 4.69% through open-market and off-market sales between late April and mid-May 2026. Hibiki Path Advisors 1 SPC maintained an unchanged 12.66% stake during the reporting period. The Cayman Islands-incorporated filers indicated an intent to provide management advice or make significant proposals, specifically pushing for capital policy improvements aimed at the core R&D strengths of the high-purity chemicals manufacturer. This large shareholding report acts as the Japanese equivalent of a US 13D filing, establishing a 17.36% block with substantial voting leverage to engage management on capital allocation and potentially release trapped value at the JPY-listed small-cap name.